chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a 65 year old female with several drug reaction/allergies and unknown pertinent medical history, who on 3/7/06 was vaccinated SC with a dose of Pneumococcal 23v polysaccharide vaccine (lot 651859/0877R). Concomitant therapy included levothyroxine Synthroid. On 3/7/06, two hours after shot, the pt developed muscle pain, joint pain, slight fever and a white strip going down her arm from the injection site. the pts muscle pain and joint pt and slight fever and a white strip going down her arm from the injection site persisted. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Pt recvd 26AUG92 & ran </=to t100 the same day & the next day;  25 hrs later pt had sz from elevated fever; t104.3 & also 105; Father had ambulance take pt to ER; EEG, spinal tap was nl;
swelling of eyes bilat;swelling of lips;itching of roof of mouth;hives on trunk anterior & posterior;extremities;tightness of chest;SOB;
Recvd a series of 3 Engerix-B dose on 16APR91 & 17MAY91 & 22OCT91; 1st 2 doses were uneventful; 23OCT91 day p/recvd 3rd vax pt exp periorbital edema, swelling of eyelids w/sinus trouble; Pt has always had sinus problems; rxd w/meds;
Myalgia, NauseaVomiting, Left arm soreness Narrative:   Other Relevant History:
This spontaneous report as received from a pharmacist refers unspecified patients of unknown age and gender. There was no information about the patients' concurrent conditions, medical history, any known allergies, reactions or concomitant medications. On an unknown date, the patient was inadvertently vaccinated with ZOSTAVAX lot # M037655 with expiration date of 29-NOV-2017, subcutaneously, for prophylaxis (dose was not reported), which had been improperly stored; diluted in properly stored sterile water diluent MRK lot # M016886 with expiration date of 07-DEC-2018, subcutaneously, for prophylaxis (dose was not reported). Administered doses of vaccines experienced previous excursions of 6-14 degrees Fahrenheit for 12 hours 15 minutes and a temperature excursion of 15-46 degrees Fahrenheit (33F) for 4 hours. Data logger was involved. No adverse effects reported. No product quality complaint was involved. No further information provided. Additional information is not expected because there was no consent to contact physician.
LAIV (FLUMIST) given on the same day patient treated for otitis externo, per father, child is doing well. No adverse events per father.
Lightheaded, nausea, headache immediately after recieving shot. Lightheaded and nausea lasted 2 days. Slight allergic reaction with left side of mouth with tingling and numbness. Lasting 2 days.  Diarrhea started on 2nd day also.
This spontaneous report as received from a registered pharmacist refers to a female patient of unknown age. On 13-OCT-2016, "a week ago", the patient was vaccinated with a dose of ZOSTAVAX (dose, route and lot # not reported). The pharmacist reported that on an unspecified date in October 2016, the patient complained of redness, soreness and itching at the injection site. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
I received the vaccine and I am breast-feeding my eight-month-old daughter. Two days after I received a vaccine she came down with 103 fever which had gotten up to 104, she has had a fever for four days now but it is down to 99, we did not have to take her to the doctor but we did call in and were told to monitor her and give her Tylenol and Motrin alternating.
2 days after my 2nd shot my throat started to hurt and lymph nodes on my neck got very swollen.  The issues continue for 10 days at which point I went to urgent care and they prescribed antibiotics.  My test for strep throat and mono came back negative.
No fever, but chills, mild headache, fatigue and generalized malaise with  myalgia, mild joint pain. Managed with Tylenol.
It started on the 12th with itching, and on the 13th it was a bumpy rash, I used cortisone and taking benadryl and it spread by the 14th. it was pretty much gone by the 16th.
This is a spontaneous report from a contactable nurse communicated to a Pfizer sales representative. This nurse reported similar events for six patients. This is the second of six reports. A patient received PREVNAR 13, on an unspecified date, for vaccination. Relevant medical history, concomitant medication and past product history were not reported. On an unknown date, following administration of the vaccination, the patient developed dark red, hard and raised swelling at the site of the injection. It was reported that no emergency room or physician visit was required. At the time of this report, the outcome of the event was unknown.
HORRIBLE BODY ACHES; CHILLS; FEVER; TIRED; WEIRD HEADACHE/PRESSURE ON FRONTAL LOBES; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNWON) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 10-APR-2021, the subject experienced horrible body aches. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced tired. On 10-APR-2021, the subject experienced weird headache/pressure on frontal lobes. Laboratory data included: Body temperature (NR: not provided) 104 degree. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the horrible body aches, chills, fever, tired and weird headache/pressure on frontal lobes was not reported. This report was non-serious.
receiving booster dose from a expired vial; Inappropriate schedule of vaccine administration; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (receiving booster dose from a expired vial) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administration) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. # 047c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (receiving booster dose from a expired vial) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administration). On 15-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administration) had resolved. At the time of the report, EXPIRED PRODUCT ADMINISTERED (receiving booster dose from a expired vial) outcome was unknown.            No concomitant medications are provided. No treatment medications are provided 2 patients received on 15Nov2021 a booster dose from an expired vial of the Moderna COVID19 vaccine original J/J lot number Moderna COVID19 vaccine expired   Most recent FOLLOW-UP information incorporated above includes: On 16-Nov-2021: Non significant follow up received
ARM WAS TENDER; KNOT/A SCAB ABOUT THE SIZE OF A PIN HEAD/SCABBING OVER AN INCH BIG, 8 INCH DEEP AND IT CONTINUE TO SCAB AND CONTINUE TO GET BIGGER; 1 INCH SCAR/IT IS SCABBING AROUND THE OUT SIDE OF THE SCAR AND IT CONTINUES TO GET BIGGER AND BIGGER/DOUBLE TO TRIPLE THE SCAR OF THE CHICKEN POX VACCINE/IT IS AWFUL; ARM SORENESS; This spontaneous report received from a patient concerned a 3 decade old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 13-MAR-2021 for covid-19 prophylaxis. The batch number was not reported and has been requested. Age at time of vaccination 24 years old. No concomitant medications were reported. On an unspecified date, the patient experienced arm was tender, knot/a scab about the size of a pin head/scabbing over an inch big, 8 inch deep and it continue to scab and continue to get bigger, 1 inch scar/it is scabbing around the out side of the scar and it continues to get bigger and bigger/double to triple the scar of the chicken pox vaccine/it is awful, and arm soreness. Laboratory data (dates unspecified) included: Physical examination A scab about the size of a pin head. Scabbing over an inch big, 8 inch deep. 1 inch scar. Treatment medications (dates unspecified) included: hydrocortisone, and colecalciferol/fish liver oil/paraffin/paraffin, liquid/petrolatum/wool fat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from arm soreness, knot/a scab about the size of a pin head/scabbing over an inch big, 8 inch deep and it continue to scab and continue to get bigger, and 1 inch scar/it is scabbing around the out side of the scar and it continues to get bigger and bigger/double to triple the scar of the chicken pox vaccine/it is awful, and the outcome of arm was tender was not reported. This report was non-serious.
Lymph node swelling and discomfort in left arm pit, heart palpitations, joint discomfort.
intense tingling in her hands and feet; This case was reported by a consumer via other manufacturer and described the occurrence of tingling feet/hands in a 60-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Covid-19 vaccine (received 1st dose on 23rd February 2021) and Covid-19 vaccine (received 2nd dose on 15th March 2021).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced tingling feet/hands. On an unknown date, the outcome of the tingling feet/hands was unknown.   It was unknown if the reporter considered the tingling feet/hands to be related to Shingles vaccine.  Additional details provided were as follows: The patient herself was the reporter for this case. The age at the vaccination was not reported. The reporter called for information about the symptoms she experienced after the administration of the Pfizer's COVID-19 vaccine immunization. The patient reports that she received her first dose and the second dose on around 8 weeks ago. The patient reported that 7 weeks after the administration of the second dose of the Pfizer's COVID-19 vaccine she started experiencing an intense tingling in her hands and feet that lasted for a week. The reporter reported that she had a similar symptom after she received the first dose of the Shingles vaccine and her physician recommended her to interrupt the immunization for Shingles. The reporter reported that she was going to contact her Physician.
24 hours post vaccination, child had fever to 100.7 deg. F. and left arm twitching followed by entire body shaking, lasting 5 minutes.
Pfizer COVID-19 Vaccine EUA  Pt received 1st dose of vaccine 1/9/21 with no initial adverse events. By the end of the day, he developed pain at the injection site, could not move arm, could not lie on left side, could not sleep. Felt pain was at injection site, not joint. Sunday morning patient took naproxen and pain subsided for a while but came back. Swelling went down a bit. On Monday, 1/11/21 pain came back, but pt was able to work through it. Pain was much better than Saturday. On Tuesday, the pain and redness was gone, but pt did still not feel 100%.
Sneezing,  runny nose, congestion. Within approximately 4-5 day,  mucus in nose became congestive and stringy when blowing nose. As of today 3/24/2022, it is still that way.
PULMONARY EMBOLISM, UNSPECIFIED. 2/1/2022 ATRIAL TACHYCARDIA  ACUTE DVT OF RIGHT POPLITEAL VEIN 2/1/2022 ATRIAL TACHYCARDIA  PULMONARY EMBOLISM, UNSPECIFIED. 2/1/2022 ATRIAL TACHYCARDIA  ACUTE DVT OF RIGHT POPLITEAL VEIN 2/1/2022 ATRIAL TACHYCARDIA
I have been sick; Weak; Chills; Fever; Lips and gums go numb for 30 min; This spontaneous case was reported by a physician and describes the occurrence of ILLNESS (I have been sick), ASTHENIA (Weak), HYPOAESTHESIA (Lips and gums go numb for 30 min), CHILLS (Chills) and PYREXIA (Fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I have been sick), ASTHENIA (Weak), HYPOAESTHESIA (Lips and gums go numb for 30 min), CHILLS (Chills) and PYREXIA (Fever). At the time of the report, ILLNESS (I have been sick), ASTHENIA (Weak), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown and HYPOAESTHESIA (Lips and gums go numb for 30 min) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.
TOOK DOSES ON DAY 1, 2 AND 4; This spontaneous case (PVX2019-734) was received from a nurse on 26-Mar-2019. It describes an adult female consumer who "took doses on day 1, 2 and 4", while being on oral Vivotif (one dose every other day) for typhoid fever prophylaxis.   Case report: The consumer did not take Vivotif doses according to schedule. The doses were taken on day 1, day 2 and day 4.  Action taken with Vivotif was not applicable.   The clinical outcome of the event "took doses on day 1, 2 and 4" was unknown.  Company's Comment: The causality of the event "took doses on day 1, 2 and 4" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took doses on day 1, 2 and 4" was considered as not applicable.
This spontaneous report was received from a 68 years old female patient with high blood pressure. Drug reactions/allergies included condeince, oxycodine, sulfa and myacin drugs. The patient was vaccinated with one time ZOSTAVAX subcutaneously in 2009 (exact date and lot # were unspecified). Concomitant medications included DIOVANN, pravastatin and ALLEGRA. In June 2012, the patient got shingles after getting the vaccine in 2009. She stated that she was still suffering from the postherpetic neuralgia (PHN). Pain killers were given as treatment for the adverse events. The patient thought unspecified medical attention. Additional information has been requested.
LOTS OF BLOOD SPILLING FROM THE ARM. HER BLACK SWEATER ABSORBED ALL THE BLOOD. I WOULD ESTIMATE THE BLOOD SPILL WAS ABOUT A SHOULDER SLEEVE WORTH OF BLOOD THAT WAS ABSORBED INTO HER SWEATER. AFTER THE BLOOD SPILL, HER ARM RAISED A BUMP ABOUT 1 INCH FROM HER ARM. I CALLED HER ON-CALL PROVIDER FROM HER DR'S OFFICE AND THEY ARE AWARE OF THE ADVERSE EVENT.
Itchiness on head; Itchy neck; Itchy body; sneezing and runny nose; Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness on head), PRURITUS (Itchy neck), PRURITUS (Itchy body), SNEEZING (sneezing and runny nose) and RHINORRHOEA (Runny nose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 041L20A) for COVID-19 vaccination.     The patient's past medical history included Melanoma (Had melanoma on the nose and had it removed two weeks ago).   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PRURITUS (Itchiness on head), PRURITUS (Itchy neck), PRURITUS (Itchy body), SNEEZING (sneezing and runny nose) and RHINORRHOEA (Runny nose). At the time of the report, PRURITUS (Itchiness on head), PRURITUS (Itchy neck), PRURITUS (Itchy body), SNEEZING (sneezing and runny nose) and RHINORRHOEA (Runny nose) had resolved.            Concomitant product use was not provided by the reporter. Events sneezing and runny nose were present since 8 months.  Treatment includes allergy medications.  The patient stated that she had some health issues but it's not because of Moderna vaccine.  The action taken with mRNA-1273 with the events was considered as not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: TCR attached. The outcome was changed from  unknown to resolved.
Significant stomach ache and loss of appetite, enough pain to wake from sound sleep, no eating the first day just Gatorade, second day broth with some noodles, third day fruit and bread and butter, fourth day 80% improvement and normal diet, 5th day 100% improvement.
arm pain; FEELING VERY BAD; This case was reported by a physician via sales rep and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm and feeling bad. On an unknown date, the outcome of the pain in arm and feeling bad were unknown.   It was unknown if the reporter considered the pain in arm and feeling bad to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced arm pain and feeling very bad after the 2nd dose.
Information has been received from a LPN concerning a patient between the age of 60 and 65 years who was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (Lot # 640981/1050L).  Subsequently the patient developed "severe local reactions at the injection site."  Follow up information received stated that the patient's entire upper arm became red and swollen.  Unspecified medical attention was sought.  The patient was treated
CDC reports 4 mo infant received DTP/OPV on 8NOV89 and died 4 hrs later.
High fever of 103, muscle aches, vaccine sight swelling and sore, continued lesser fever for three days. Treatments: ibuprofen and bed rest.
Fever 100.7; Chills; Body aches; Shakes; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 14Apr2021 at 16:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 20:00, the patient experienced fever 100.7, chills, body aches, shakes and headache. On 14Apr2021 at 20:00, the patient underwent body temperature test and the result was found to be 100.7 (units unspecified). Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever 100.7, chills, body aches, shakes and headache were recovered on an unknown date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Administrative deviation only; no adverse event resulted from this deviation.  This patient received a mixed series of COVID-19 vaccine (one dose of Moderna and one dose of Pfizer - box #4 above reflects the date of the second dose). The decision to administer a mixed series to the patient was due to an "exceptional circumstance" stemming from the unavailability of the first vaccine product (Moderna) at the time the second dose was due.  We understand that although CDC provides considerations for a mixed series in exceptional circumstances (such as a vaccine shortage, which was the case here), a mixed series is still considered an administration deviation that requires VAERS reporting. Note that the date of vaccination on this form reflects the date the patient received his/her second vaccine dose.                                                                     Administrative deviation only; no adverse event resulted from this deviation.  This patient received a mixed series of COVID-19 vaccine (one dose of Moderna and one dose of Pfizer - box #4 above reflects the date of the second dose). The decision to administer a mixed series to the patient was due to an "exceptional circumstance" stemming from the unavailability of the first vaccine product (Moderna) at the time the second dose was
9/25/08 40 hours after receiving DTaP vaccine pt developed swelling of lips and hives. Hives and lip swelling recurred x 2d. Pt developed fever 9/24/08-9/26/08 Tmax 103 F. Pt did not have GI or respiratory sx with hives/lip swelling.
Drowsiness; Dizziness; arm pit soreness; Fatigue; Chills; shoulder soreness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness), AXILLARY PAIN (arm pit soreness), FATIGUE (Fatigue) and CHILLS (Chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness), AXILLARY PAIN (arm pit soreness), FATIGUE (Fatigue), CHILLS (Chills), ARTHRALGIA (shoulder soreness) and NAUSEA (Nausea). The patient was treated with ACETYLSALICYLIC ACID (ASPRIN) at a dose of UNK dosage form. At the time of the report, SOMNOLENCE (Drowsiness), DIZZINESS (Dizziness), AXILLARY PAIN (arm pit soreness), FATIGUE (Fatigue), CHILLS (Chills), ARTHRALGIA (shoulder soreness) and NAUSEA (Nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. Patients' pertinent medical history and drug reactions or allergies were not reported. On unknown dates in 2016 (reported as since March 2016), patients were vaccinated with improperly stored ZOSTAVAX 1 dose (lot number, expiration date and route of administration were not reported). Concomitant therapy was not reported. No adverse effect was reported. No product quality complaint (PQC) was involved. This is one of the two reports received from the same reporter. Additional information has been requested.
1/ 8 developed LUE injection site pain and left axillary pain. Rates 10/10.  Motrin prescribed.
Patient was given a Flu mist vaccine. No adverse events noted (tried to notify pt's mother no response will send letter).
chills,  body pain, high fever ( 103), myalgia, dryness of mouth and nose, loss of taste, lethargy, weakness, very low or no energy, could not sleep for 7- 8 days in night time because of fever and chills,  severe headache, diarrohea for first 6 days, so much weakness in muscles and nerves can't even move position during night time.  weakness is to such a level that may not make it back.